Jennifer Sy

Insider Reports History

Location
Irvine, CA
Signature
/s/ Alexander Wilson, as attorney-in-fact for Jennifer Sy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jennifer Sy:

Company Role Class Num Shares Value Price $ Report Date Ownership
AEON Biopharma, Inc. Chief Accounting Officer Restricted Stock Units 925,925 21 May 2025 Direct
AEON Biopharma, Inc. Chief Accounting Officer Stock Option 48,063 31 Aug 2024 Direct
AEON Biopharma, Inc. Chief Accounting Officer Class A Common Stock 18,010 31 Aug 2024 Direct

Insider Reports Filed by Jennifer Sy

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AEON AEON Biopharma, Inc. 21 May 2025 1 $0 4 Chief Accounting Officer 23 May 2025, 16:55
AEON AEON Biopharma, Inc. 31 Aug 2024 2 $0 4 PRINCIPAL ACCOUNTING OFFICER 04 Sep 2024, 21:53
AEON AEON Biopharma, Inc. 17 May 2024 0 $0 3 PRINCIPAL ACCOUNTING OFFICER 24 May 2024, 20:02